Our in vitro results demonstrated that CTRP9 decreases cholesterol loading‐induced pro‐inflammatory cytokine secretion by VSMCs, suggesting that CTRP9 may indeed be effective in suppressing atherosclerosis. The gene discussed is C1QTNF9; the disease is atherosclerosis.